Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced Malignancies
Incyte Corporation
Incyte Corporation
Young Adult Survivors United
Eisai Inc.
Stingthera, Inc.
Fate Therapeutics
City of Hope Medical Center
University Health Network, Toronto
Case Comprehensive Cancer Center
Tocagen Inc.
Mayo Clinic
Incyte Corporation
Mirna Therapeutics, Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins